Fenofibric Acid Capsule, Delayed Release
Product Images NDC 33342-295

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 33342-295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

174 (Fenofibric Acid 135 mg 10x14s)

Fenofibric Acid Delayed-Release Capsules 135 mg packaging label from Macleods Pharmaceuticals Limited. The label shows 140 capsules per package and includes storage instructions, manufacturer details, and a barcode. The label states the product is for Rx use only and specifies the active ingredient strength as 135 mg per capsule.*

FDA Label Image

164 (Fenofibric Acid 135 mg 90s)

Label for Fenofibric Acid Delayed-Release Capsules, 135 mg, manufactured by Macleods Pharmaceuticals Limited. The label indicates a package size of 90 capsules and notes storage instructions at controlled room temperature (20° to 25°C). The label also includes the National Drug Code (NDC) 33342-295-10 and warnings to keep out of reach of children and not to accept if the bottle seal is broken or missing.*

FDA Label Image

163 (Fenofibric Acid 45 mg 10x10s)

Packaging label for Fenofibric Acid 45 mg delayed-release capsules by Macleods Pharmaceuticals Limited. The label shows the dosage strength 45 mg prominently on all sides. It indicates a package size of 100 capsules (10 x 10 unit-dose) and includes manufacturer information: Macleods Pharma USA, Princeton, NJ, and Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. Storage instructions and warnings about blister cards not being child resistant are also visible.*

FDA Label Image

186 (Fenofibric Acid 45 mg 90s)

Fenofibric Acid Delayed-Release Capsules 45 mg, oral dosage form, 90 count bottle label. Manufactured by Macleods Pharmaceuticals Ltd and labeled for Macleods Pharma USA, Inc. The label includes storage instructions and a warning to keep out of reach of children.*

FDA Label Image

111 (Fenofibric Acid Structure)

Chemical structure of fenofibric acid shown as a molecular diagram with aromatic rings, chlorine atom, carbonyl groups, and other functional groups consistent with fenofibric acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.